No rotating staff
Injection-Based Administration Subcutaneous injections: All GLP-1 RAs are administered via subcutaneous injection Prefilled pens: Most common delivery system, allows for self-administration Auto-injectors: Simplify the process for patients with dexterity issues Multi-dose pens: Require dose dialing and needle attachment Dosing frequency: Daily: Liraglutide (Saxenda, Victoza), some formulations of exenatide (Byetta) Weekly: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide extended-release (Bydureon) Titration schedules: Most FDA-approved GLP-1 RAs require gradual dose escalation to minimize gastrointestinal side effects
Lactate Dehydrogenase (LDH) Assay In this assay performed on HaCaT keratinocytes cells, the cells were treated with GHK, GHK-Cu, CuCl 2 and Cu(OAc) 2 for 30 mins at 7 different concentrations each, ranging from 0.0058 to 5800 M0.0058 M, 0.058 M, 0.58 M, 5.8 M, 58 M, 580 M, 5800 M
Nausea Vomiting Constipation Diarrhea Acid reflux Bloating Reduced appetite Stomach discomfort Most side effects improve gradually after the body adapts to treatment
Plant Foods for Human Nutrition, 70 (4), 441-453
How the natural GLP-1 hormone works It helps with glucose (blood sugar) regulation and improves insulin sensitivity, which can also aid weight loss